MetaCap

Palatin Technologies Inc. (PTN)

NASDAQ: PTNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.58-0.35 (-7.10%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PTN stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$2.96
52-week range
4.51 – 31.00
Day range
4.56 – 4.99
Volume / Avg
20.48K / 71.93K
Beta
—

52-week range

$4.51$31.00

PTN stock today

Palatin Technologies (PTN) closed at $4.58 on Nov 20, down 7.10% (-$0.35), versus the S&P 500's 3.70% decline. Trading was light, with 20.48K shares changing hands, about 28% of the average daily volume. At this level, PTN sits near the bottom of its 52-week range of $4.51 to $31.00: 85.2% below the high, set on Dec 15, 2025 and 1.6% above the low.

PTN is down 70.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 79.9%. Palatin Technologies has posted a net loss over the last twelve months (EPS of -$2.96), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Palatin Technologies

Company profile

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity completed Phase 2 clinical trial; completed a phase 2 of diabetic nephropathy It also provides pl9643 for dry eye disease; and oral PL8177 for inflammatory bowel diseases. licensing arrangements and other strategic transactions to advance and maximize the value of certain product candidates and program for the treatment of retinal diseases and with Altanispac Labs for PL9643 for the treatment of dry eye disease; and oral PL8177 for the treatment inflammatory bowel diseases.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Carl Spana Ph.D.
Headquarters
Princeton, NJ
Employees
25

Financial highlights

Full financials

In fiscal 2026, Palatin Technologies generated $8.8 million in revenue, up 0.0% from fiscal 2025. Palatin Technologies reported a net loss of $8.4 million, compared with a loss of $17.3 million a year earlier. Operating margin was -98.2%.

Palatin Technologies annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$8.83M$0$4.49M$4.85M$1.47M
Growth—-100.00%-7.49%+230.53%+878.62%
Net income$-8.38M$-17.31M$-29.74M$-24.04M$-36.20M
EPS (diluted)$-2.96$-32.15$-101.16——

Analyst forecast

Forecast

Consensus (3 analysts)

strong_buy

Avg. price target

$53.50+1068.12%

  • Strong buy 1
  • Buy 2
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $47.50High $60.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 17, 2026
EPS actual vs est.
$4.26 vs $-0.32
Surprise
+1431.25%

PTN news

All PTN news

Palatin Technologies peers

Health Care sector
PTN peer companies
CompanyPrice% ChgMarket capCompare
MBRXMoleculin Biotech Inc.7.74-2.40%$8.22Mvs PTN
QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares1.29-9.15%$8.29Mvs PTN
DAREDare Bioscience Inc.0.4074-9.87%$8.01Mvs PTN
CLRBCellectar Biosciences Inc.0.797-11.50%$8.00Mvs PTN
HINDVyome Holdings Inc.1.20-17.24%$8.42Mvs PTN
PHIOPhio Pharmaceuticals Corp.0.656-8.25%$7.84Mvs PTN
LEXXLexaria Bioscience Corp.4.03-10.24%$8.49Mvs PTN
BIVIBioVie Inc. Class A0.80-12.07%$8.58Mvs PTN

Indexes, lists and sector

Palatin Technologies stock FAQ

What is Palatin Technologies's stock price today?

PTN last traded at $4.58 as of Nov 20, 4:00 PM EST, down 7.10% on the day. Prices are delayed at least 15 minutes.

Does Palatin Technologies pay a dividend?

No. Palatin Technologies does not currently pay a regular cash dividend.

Who is Palatin Technologies's CEO?

Dr. Carl Spana Ph.D. is the chief executive officer of Palatin Technologies Inc., which has about 25 employees.

Has PTN ever split its stock?

Yes. The most recent PTN stock split was a 1-for-50 split on Aug 12, 2025, one of 3 splits on record.

What is the PTN 52-week high?

The 52-week high for PTN is $31.00 and the 52-week low is $4.51. The stock is currently 85.2% below its high.

Compare PTN